IL1R1 and Parkinson disease: Moreover, systemic adenoviral mediated overexpression of IL-1β potentiated dopaminergic loss in the 6-hydroxydopamine rodent model of PD [72], and inhibition of IL-1R reduced the level of dopaminergic loss that was potentiated by intra nigral injection of LPS into the same model [72,73].